Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
TL;DR
The U.S. and China have approved the sale of TikTok's U.S. business to a consortium led by Oracle Corp. and Silver Lake, resolving a multiyear political standoff over data security. Oracle,...
TL;DR
Nestlé has formally initiated the sale of a stake in its €5 billion water business, attracting significant interest from private equity firms. Banks are structuring a substantial debt...
TL;DR
BlackRock's HPS Investment Partners deployed $50 million into Malaysia-based Teleport Media Asia, marking its first Asia private credit transaction since BlackRock's 2023 acquisition of HPS....
TL;DR
PayPal Holdings has agreed to acquire Tel Aviv-based Cymbio, a multi-channel orchestration platform, to accelerate its agentic commerce capabilities. The deal, which builds on a partnership...
TL;DR
Former executives of an unnamed health tech company that went public via a SPAC merger have agreed to a $10 million settlement to resolve investor lawsuits. The claims alleged executives...
TL;DR
EQT AB has agreed to acquire U.K.-based Coller Capital for a base price of $3.2 billion, with up to $500 million in additional cash contingent on performance, primarily funded through newly...
TL;DR
Deutsche Boerse Group is acquiring Amsterdam-listed fund distribution platform Allfunds for €5.3 billion ($6.2 billion), announced on January 21, 2026. The transaction values Allfunds at...
TL;DR
Telefónica is delaying the divestiture of its Venezuelan operations, Telefónica Movistar, despite significant pressure from human rights groups and international scrutiny over its complicity...
TL;DR
GSK is set to acquire clinical-stage biotech Rapt Therapeutics for $2.2 billion in equity, or $58 per share in cash, with a net cash commitment of $1.9 billion. This acquisition grants GSK...
TL;DR
Montagu Private Equity and Kohlberg & Company have acquired Teleflex Inc.'s vascular access and interventional product lines in a $1.5 billion carve-out transaction, announced January 20,...
